So, pharmaceutical companies started investigating the use of GLP-1s for weight-management purposes, and the first GLP-1 weight-loss drug, Saxenda (liraglutide), was approved by FDA in 2014 (it was previously approved to treat diabetes under the name Victoza)
De Silva A, Salem V, Long CJ, Makwana A, Newbould RD, Rabiner EA, et al
266, 1000 Ljubljana Spar partner Kobilje Directions Kobilje 36, 9227 Kobilje Spar Partner Ig Directions Gasilska ulica 10, 1292 Ig Spar Partner Makovci Directions Makovci 48c, 9202 Makovci Spar Partner Sv
Kidney Stones Kidney stone(s), a condition also known as nephrolithiasis, is one of the most common kidney diseases
Common problems include nausea, facial flushing, and increased darkening of moles or freckles
In the last decade, the FDA has recognized their effectiveness as anti-obesity medications